Minimize Uncertainty – Make Informed Decisions – Succeed

Public_Health

Public Health Today—14 November, 2025

November 14, 2025gene editing,novartis,BioPharma and Tech News,tuberculosis,Lupus,Atrial fibrillation,Xenotransplantation,Ultra-processed foods,Public Health News,malariamyocardial infarction,climate change and health

This weekly roundup spans late-stage trial wins, real-world and epidemiologic…

by LucidQuest

Vaccines_News

Vaccines Video Recap—November 14, 2025

November 14, 2025zika,cancer,breast cancer,BioPharma and Tech News,COVID-19,Valneva,Akeso,Transgene,GC Biopharma,Anixa Biosciences,Vaccine news,malaria,choleracastlevax,anthrax

This biweekly video recap highlights early-phase immunogenicity and safety…

by LucidQuest

Vaccines

Vaccines Today—November 14, 2025

November 14, 2025breast cancer,BioPharma and Tech News,melanoma,Pancreatic cancer,Akeso,Anixa Biosciences,Evaxion,personalized cancer vaccine,Vaccine news,Lassa fevermalaria,cholera

This week’s vaccines report covers early-phase safety/immunogenicity, durable…

by LucidQuest

Respiratory

Respiratory Video Recap—November 14, 2025

November 14, 2025gsk,COPD,BioPharma and Tech News,Hanmi Pharma,Idiopathic Pulmonary Fibrosis,Endeavor BioMedicines,pulmonary arterial hypertension,Respiratory News,Rein Therapeutics,MannKind,Otsuka,calluna pharmacalcimedica,severe eosinophilic asthma

This respiratory video recap spans late-stage trial launches, regulatory…

by LucidQuest

Respiratory

Respiratory Today—November 14, 2025

November 14, 2025BioPharma and Tech News,Idiopathic Pulmonary Fibrosispulmonary arterial hypertension,Respiratory News,Rein Therapeutics,Otsuka,multidrug-resistant tuberculosis,nontuberculous mycobacteria,quabodepistat,HDAC inhibitor

Explore this week’s respiratory highlights, including Phase 3 starts, Phase 2b…

by LucidQuest

Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: T-Therapeutics Series A extension to $91m

November 14, 2025Oncology,venture capital,clinical trials,biopharma,Bispecifics,Lucid Diligence Brief,payer access,HTA,TCR therapeuticsCambridge cluster

Lucid Diligence Brief: T-Therapeutics Series A extension to $91m Professional…

by Timos Papagatsias

Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: General Proximity and Daiichi Sankyo multi-target induced-proximity oncology deal

November 13, 2025Oncology,biopharma,Biomarkers,Lucid Diligence Brief,payer access,ADCs,investor diligence,induced proximity,platform deals,discovery alliancesR&D strategy

Lucid Diligence Brief: General Proximity and Daiichi Sankyo multi-target…

by Timos Papagatsias

Cell_Gene_Therapy

Cell and Gene Therapy Video Recap—November 13, 2025

November 13, 2025Meira GTx,BioPharma and Tech News,Eli Lilly,Angelman Syndrome,mCRC,MavriX Bio,Cell and Gene Therapy News,Intellia Therapeutics,ATTR amyloidosistenaya therapeutics,gallant

This biweekly Cell and Gene Therapy video spotlights the most important trends…

by LucidQuest

Cell_Gene_Therapy

Cell and Gene Therapy Today—November 13, 2025

November 13, 2025BioPharma and Tech News,HEART FAILUREEli Lilly,Angelman Syndrome,Cell and Gene Therapy News,CAR T cell therapy,hypertrophic cardiomyopathy,Leber congenital amaurosis,ATTR amyloidosis,CRISPR gene editing,AAV vectors,Natural killer cell therapy

This week’s cell and gene therapy update covers key developments including…

by LucidQuest

Cardiovascular

Cardiovascular Today—November 13, 2025

November 13, 2025remote patient monitoring,bayer,BioPharma and Tech News,HEART FAILURE,finerenone,hypertension,Cardiovascular News,mitral regurgitation,transcatheter mitral valve replacement,polygenic risk scoreOtsuka,iRhythm Technologies

This week’s cardiovascular news highlights new clinical trial results, digital…

by LucidQuest

Rare Disease news

Rare Disease Today—November 13, 2025

November 13, 2025ucb,BioPharma and Tech News,Stargardt Disease,Beta Thalassemia,MHRA,Rare Disease News,AAV Gene Therapy,Rare disease regulation,TK2 deficiency,Usher syndrome type 1Bprimary biliary cholangitis,Mirum Pharmaceuticals

This week’s rare disease update spotlights key regulatory milestones,…

by LucidQuest

Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Chiesi partners with Aliada (AbbVie) on BBB platform for LSDs

November 13, 2025CNS,Regulatory,rare disease,biopharma,Lucid Diligence Brief,payer access,diligence,partnerships,clinical translation,lysosomal storage disorders,BBB deliveryenzyme replacement

Lucid Diligence Brief: Chiesi partners with Aliada on BBB platform for LSDs…

by Timos Papagatsias

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required
You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.